FDA Lays Out Final Rules for Pediatric Labeling

Drug Industry Daily
A A
The FDA released a final guidance on pediatric labeling of prescription drugs that, among other recommendations, calls for black box warnings on medicines with inactive ingredients that might be dangerous to babies and children.

To View This Article:

Login

Subscribe To Drug Industry Daily